Eli Lilly's Eloralintide Shows Promise for Osteoarthritis Knee Pain in Obese Patients
Eli Lilly is conducting two independent studies to evaluate the efficacy and safety of Eloralintide (LY3841136) in adults with knee osteoarthritis and obesity.
Asset / Drug
Drug and asset intelligence for Osteoarthritis Knee with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.